What is the ticker symbol for AVROBIO?

AVROBIO trades under the ticker AVRO on NASDAQ.

What sector does AVROBIO operate in?

AVROBIO is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AVRO in a portfolio?

PortView shows AVRO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

AVROBIO (AVRO) Stock Analysis

NASDAQHealthcareBiotechnology

$1.40-1.41%

1-year price historyRange $0.89 – $1.62

52-week range$1.40

$1.38$19.80

What AVROBIO does

AVROBIO, Inc. is a biotechnology firm in the clinical development stage, dedicated to advancing gene therapies. The company specializes in an ex vivo lentiviral-based approach, aiming to address rare genetic conditions worldwide through a single therapeutic administration. Their innovative methodology involves collecting hematopoietic stem cells directly from patients. These cells are then genetically engineered using a lentiviral vector, which introduces functional copies of the specific gene that is deficient or defective in the patient's condition. Among its pipeline, AVROBIO's lead candidate is AVR-RD-01, designed for the treatment of Fabry disease. The company's therapeutic portfolio also includes AVR-RD-02, currently undergoing Phase 1/2 clinical trials for Type 1 Gaucher disease, alongside AVR-RD-03 for Pompe disease, AVR-RD-04 for cystinosis, and AVR-RD-05 for Hunter syndrome. Additionally, AVR-RD-06 is in preclinical development, targeting Type 3 Gaucher disease. Established in 2015, AVROBIO maintains its corporate headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

$5.24M

P/E (TTM)

0.17

EPS (TTM)

$8.28

Beta

1.22

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$16.17

200-day avg

$16.46

52-week high

$19.80

52-week low

$1.38

CEO

Erik John Ostrowski

ETFs linked to AVRO

Broad-market and Healthcare sector ETFs an investor holding AVROBIO is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AVRO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AVRO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for AVROBIO?: AVROBIO trades under the ticker AVRO on NASDAQ.
Which exchange is AVRO listed on?: AVRO is listed on NASDAQ.
What sector does AVROBIO operate in?: AVROBIO is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AVRO in a portfolio?: PortView shows AVRO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.